Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee-Reference-Cited by-同舟云学术

Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

Published:2024-08 Issue:8 Volume:25 Page:e374-e387
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lin Yi,Qiu Lugui,Usmani Saad,Joo Chng Wee,Costa Luciano,Derman Benjamin,Du Juan,Einsele Hermann,Fernandez de Larrea Carlos,Hajek Roman,Ho P Joy,Kastritis Efstathios,Martinez-Lopez Joaquin,Mateos Maria-Victoria,Mikhael Joseph,Moreau Philippe,Nagarajan Chandramouli,Nooka Ajay,O'Dwyer Michael,Schjesvold Fredrik,Sidana Surbhi,van de Donk Niels WCJ,Weisel Katja,Zweegman Sonja,Raje Noopur,Otero Paula Rodriguez,Anderson Larry D,Kumar Shaji,Martin Tom

Publisher

Elsevier BV

Reference90 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment;Ludwig;Oncologist,2020

3. Novel agents as main drivers for continued improvement in survival in multiple myeloma;Puertas;Cancers,2023

4. Sequencing of myeloma therapy: finding the right path among many standards;Rajkumar;Hematol Oncol,2021

5. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline;Mikhael;J Clin Oncol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCMA-directed therapy for early relapsed and/or refractory multiple myeloma;Nature Reviews Clinical Oncology;2024-07-19